Published in Proteomics Weekly, November 14th, 2005
"DNA vaccination is discussed as having the potential of improving therapy of type I allergies. A mouse model was used to investigate the effect of DNA vaccination against sensitization with the clinically relevant Phl p 5b major allergen from timothy grass pollen in an immunoprophylactic experimental setup," researchers in Germany report.
"Pre-treating the mice with Phl p...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly